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Abstract
Despite the substantial knowledge on the antidiabetic, antiobesity and antihypertensive ac-
tions of tungstate, information on its primary target/s is scarce. Tungstate activates both the
ERK1/2 pathway and the vascular voltage- and Ca2+-dependent large-conductance BKαβ1
potassium channel, which modulates vascular smooth muscle cell (VSMC) proliferation and
function, respectively. Here, we have assessed the possible involvement of BKαβ1 chan-
nels in the tungstate-induced ERK phosphorylation and its relevance for VSMC prolifera-
tion. Western blot analysis in HEK cell lines showed that expression of vascular BKαβ1
channels potentiates the tungstate-induced ERK1/2 phosphorylation in a Gi/o protein-
dependent manner. Tungstate activated BKαβ1 channels upstream of G proteins as chan-
nel activation was not altered by the inhibition of G proteins with GDPβS or pertussis toxin.
Moreover, analysis of Gi/o protein activation measuring the FRET among heterologously ex-
pressed Gi protein subunits suggested that tungstate-targeting of BKαβ1 channels pro-
motes G protein activation. Single channel recordings on VSMCs from wild-type and β1-
knockout mice indicated that the presence of the regulatory β1 subunit was essential for the
tungstate-mediated activation of BK channels in VSMCs. Moreover, the specific BK channel
blocker iberiotoxin lowered tungstate-induced ERK phosphorylation by 55% and partially re-
verted (by 51%) the tungstate-produced reduction of platelet-derived growth factor (PDGF)-
induced proliferation in human VSMCs. Our observations indicate that tungstate-targeting
of BKαβ1 channels promotes activation of PTX-sensitive Gi proteins to enhance the
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tungstate-induced phosphorylation of ERK, and inhibits PDGF-stimulated cell proliferation
in human vascular smooth muscle.
Introduction
Tungstate has antidiabetic and antiobesity actions in several animal models: 1) tungstate treat-
ment normalizes hepatic carbohydrate metabolism [1, 2]; 2) stimulates insulin secretion and
regenerates pancreatic β-cell population [3]; 3) mimics the effect of insulin on hepatocytes (but
in an insulin receptor independent manner) by increasing glycogen synthesis and deposition
[4]; 4) increases the production and translocation of the insulin-regulated glucose transporter
GLUT4 in muscle [5]; 5) favors thermogenesis and lipid oxidation in adipose tissue [6]; and 6)
modulates hypothalamic gene expression by activation of the leptin-signaling pathway respon-
sible for the regulation of food intake and energy expenditure [7]. In addition, tungstate also re-
duces blood pressure in experimental animal models of both hypertension [8, 9] and metabolic
syndrome [10].
Despite this knowledge on tungstate effects, our understanding of the underlying molecular
mechanisms is incomplete. In this respect, it has been suggested that activation of several kinases
(extracellular signal-regulated kinases (ERK) 1/2 and JAK2) by tungstate can lead to some of its
antidiabetic and antiobesity actions [4, 5, 7]. Indeed, tungstate stimulates ERK phosphorylation
in different cell types, including CHO cells, Leydig cells, neurons, and hepatocytes, leading to the
phosphorylation (inactivation) of the glycogen synthase kinase-3β that in turn modulates cell
function [4, 11, 12]. Although the nature of tungstate targets upstream of ERK phosphorylation
is not fully known, the involvement of a non-canonical pathway that requires pertussis toxin
(PTX)-sensitive Gi/o proteins has been proposed recently, at least in CHO and liver cells [13].
Tungstate’s antihypertensive actions seem to be achieved by inhibition of endothelial xan-
thine oxidase [8] and by activation of the large-conductance voltage- and Ca2+-activated K+
(BK) channel in vascular smooth muscle [14]. These BK channels are mostly formed by tetra-
mers of the pore-forming α subunit (encoded by a single gene, KCNMA1) along with the regu-
latory β1 subunit (encoded by the KCNMB1 gene). This accessory β1 subunit favors BK
channel activation by voltage and Ca2+ [15–17]. BK channels are pivotal in the regulation of ar-
terial tone, where they facilitate a negative feedback mechanism which opposes the vasocon-
striction driven by Ca2+ entry through voltage-gated L-type Ca2+ channels. Activation of L-
type Ca2+ channels by membrane depolarization not only leads to vascular smooth muscle con-
traction but also promotes the opening of ryanodine receptors in the sarcoplasmic reticulum.
BK channels are activated in vascular smooth muscle by local and transient Ca2+ increases
(“Ca2+ sparks”) caused by the opening of a cluster of ryanodine receptors in the sarcoplasmic
reticulum membrane adjacent to the cell membrane. The efflux of K+ through BK channels is
sufficient to hyperpolarize the membrane potential limiting membrane depolarization, Ca2+ in-
flux via voltage-operated L-type Ca2+ channels, and smooth muscle contraction [18]. Because
of its action on BK channel function, the presence of the regulatory β1 promotes this negative
impact on vascular resistance [19, 20]. Moreover, the presence of β β1 is required for channel
modulation by a series compounds [21–25], in particular, tungstate. Still, the putative binding
site of tungstate has been mapped to the pore-forming α channel subunit, in close proximity to
the Mg2+ binding site [14, 26].
It has been suggested that K+ channels serve as upstreammodulators of the ERK pathway [27,
28]. As a general biophysical principle, cell membrane hyperpolarization caused by K+ channel
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activation increases the driving force for Ca2+ entry, and the resulting increase in intracellular
Ca2+ concentration enhances cell proliferation by stimulating Ca2+-sensitive signaling steps.
However, additional roles of K+ channels as direct transducers of intracellular signals, beyond
their ion-conducting function and hyperpolarizing action, are emerging [29]. For example, it has
been suggested that the intermediate-conductance Ca2+-dependent K+ (IK1) channel (also
known as KCa3.1 or SK4, and encoded by the KCNN4 gene) can promote cell proliferation inde-
pendent of K+ conductance, by direct interaction with ERK1/2 and JNK signaling pathways [30].
Phenotypic modulation of vascular smooth muscle cells (VSMCs) from a contractile pheno-
type toward a proliferative phenotype and concomitant vascular remodeling is a hallmark of
vascular pathologies such as hypertension, hyperlipidemia or neointima formation after bal-
loon catheter intervention [31, 32]. At the molecular level, such phenotypic remodeling has
been linked to changes in the expression of many genes including K+ channels such as KCa3.1
[32] and voltage-gated K+ channels belonging to the KV1/5 subfamilies [33, 34]. Although the
activation of ERK1/2 has been involved in the proliferation of VSMCs induced by growth fac-
tors such as platelet-derived growth factor (PDGF) [35], dedifferentiated VSMCs gradually re-
gain contractile functions in a process mediated by PTX-sensitive G proteins (in particular,
Gβγ dimmers) that also relies on ERK pathway activation [36, 37]. Such controversial role of
the ERK pathway in VSMC phenotypic modulation can be explained at least in part by differ-
ences in both strength and duration of ERK1/2 phosphorylation [34, 35].
Given that tungstate promotes the activity of both the ERK1/2 pathway (in a Gi/o protein-
dependent manner) and the BKαβ1 channel, we hypothesized and found that BK channel plays
a mechanistic regulatory role in the tungstate-induced ERK phosphorylation that is relevant
for VSMC proliferation.
Materials and Methods
Reagents
Sodium tungstate, Pertussis Toxin (PTX), GDPβS, Noradrenaline (NA) and EGF were from
Sigma-Aldrich. Iberiotoxin (IbTX) was from Alomone Labs Ltd. (Jerusalem, Israel). Tissue cul-
ture media and supplements were from Sigma and Invitrogen. Fetal bovine serum (FBS) was
from Gibco. Phospho-ERK antibody (1:1,000 in BSA blocking solution) was purchased from
Cell Signaling TECHNOLOGY. Monoclonal mouse anti-β-Actin 1:10,000 (ab8226, Abcam,
Cambridge, UK), was used in vascular smooth muscle cells (VSMCs) Western blots as loading
control. For PTX experiments, transfected cells were incubated with 100–500 ng/ml PTX in
culture medium, at 37°C and for 24–28 hours before electrophysiological recording or Western
blot assays.
cDNA constructs
Human β1 subunit (KCNMB1) of the BK channel (cloned into pcDNA3) was a gift from Dr.
Ligia Toro (University of California—Los Angeles, Los Angeles, California, USA). Human α
subunit (KCNMA1) of the BK channel (cloned into pcDNA3) was supplied by Dr. Ramón
Latorre, (Centro de Neurociencias de Valparaíso, Valparaíso, Chile). Rat Gα subunit (tagged
with YFP), human Gβ subunit (tagged with CFP) and adrenergic α2A receptor (α2A-AR) (all
cloned into pcDNA3) were kindly supplied by Dr. Moritz Büneman (Department of Pharma-
cology and Toxicology, University of Würzburg—Germany).
Human VSMCs collection and culture
Human renal arteries belonging to the COLMAH collection of the HERACLES network
(http://www.redheracles.net/plataformas/en_coleccion-muestras-arteriales-humanas.html)
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were obtained from donors at the Clinic Hospitals of Barcelona and Valladolid. Vessels were
placed in a Dulbecco’s modified Eagle’s medium (DMEM), for cell isolation. Samples were re-
ceived within 24 hours after intervention and kept at 4°C. Cultured vascular smooth muscle
cells (VSMCs) were obtained from cell outgrowth of vessels explant as described elsewhere
[33]. Briefly, VSMCs were isolated from the medial layer of the vessel kept in DMEM after
manual removal of both adventitia and endothelial layers under a dissection microscope. Once
cleaned, the muscle layer was cut in 1 mm2 pieces that were seeded in 35 mm Petri dishes treat-
ed with 2% gelatin (Type B from bovine skin, Sigma) or collagen (6 well multidish collagen,
Thermo Scientific), in DMEM supplemented with 20% FBS, penicillin-streptomycin
(100 U/ml each), 5 μg/ml fungizone, and 2 mM L-glutamine (Lonza) at 37°C in a 5% CO2 hu-
midified atmosphere. Migration and proliferation of VSMCs from the explants were evident
within 10–15 days. Confluent cells were trypsinized and seeded at 1/3 density and VSMCs
were subjected to several (up to 8) passages in control DMEM supplemented with 5% FBS,
penicillin-streptomycin (100 U/ml each), 5 μg/ml fungizone, 2 mM L-glutamine, 5 μg/ml Insu-
lin, 1 ng/ml bFGF and 5 ng/ml EGF.
Transfection of HEK293 cell lines
For electrophysiological analysis, HEK293 cells were transfected using polyethylenimine
ExGen 500 (Fermentas Inc., Hanover, MD, USA), following the manufacturer’s instructions
[seven equivalents of polyethylenimine per 3.3 μg of cDNAs (cloned into pcDNA3 vector) ex-
pressing the human BK α subunit together with the human β1 subunit (1:2 ratio) and the trans-
fection reporter pEGFPN1].
For FRET studies, HEK293 cells, HEKα cells (expressing constitutively the human α subunit
of the BK channel) and HEKαβ1 cells (constitutively expressing the bovine α and β1 subunit of
the BK channel) were transiently transfected with rat Gα-YFP (YFP inserted between position
91 and 92), human CFP-Gβ fusion protein (CFP fused to the N-terminus) and the Gγ subunit
using polyethylenimine ExGen 500 (Fermentas Inc., Hanover, MD, USA). For control FRET
experiments, the cDNA corresponding to α2A-AR was also co-expressed in HEK293 cells.
Western blot analysis
The different HEK293 cell lines were grown to confluence and then deprived of FBS overnight.
For the study of ERK1/2 phosphorylation in human renal VSMCs, 20,000 cells were seeded on
12 mm diameter plates in control medium and after 24 hours, cells were made quiescent with
serum-free medium for 48 hours. The different treatments (Tungstate, PDGF, IGF, EGF or
tungstate + IbTX) were performed in serum-free medium. Plates were flash frozen in liquid ni-
trogen and processed for protein extract preparation. Protein concentration was measured
using the BCA Protein Assay (Pierce, USA). Proteins were separated by SDS—PAGE loading
20 μg of total protein per lane, transferred to nitrocellulose membranes (Schleicher and Schuell,
Dassel, Germany) and immunoblotted with selected antibodies. Proteins were visualized using
an enhanced chemiluminescence detection system (GE Healthcare, UK) or with the VersaDoc
4000 Image System (BioRad) with chemiluminescence reagents (SuperSignal West Femto
Chemiluminescent Substrate, Pierce Biotechnology). The relative amount of protein was calcu-
lated by densitometric analysis of bands and, in the case of VSMCs, normalized to their corre-
sponding β-actin signals using the Fiji (Image J) software.
Electrophysiology
Equation 1 Inside-out BK currents were recorded in macropatches from EGFP-positive HEK
cells 2–3 days after transfection. Borosilicate glass patch pipettes had a tip resistance of 2–3
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MO and were filled with a solution containing (in mM): 140 KCl, 1.2 MgCl2, 0.15 CaCl2, 5
EGTA, 10 HEPES (300 mOsm/l, pH 7.35). 0 Ca2+ solution (nominal 0 Ca2+) bathing the cyto-
plasmic face of the membrane patch, to which 1 mMWO4
2- was added for 5–10 minutes after
a series of control recordings, contained (in mM): 140 KCl, 0.7 Mg2+, 5 EGTA, 10 HEPES
(300 mOsm/l and pH 7.25). We compensated series resistance to 80–90% because of the large
magnitude of BK currents. When used, GDPβS was added to the 0 Ca2+ bath solution 5 min-
utes before starting the electrophysiological experiments. For current-activation studies, mem-
brane macropatches were clamped at 0 mV, pulsed for 150 milliseconds from—100 mV to
+200 mV in 10 mV steps, and repolarized to—80 mV for 20 milliseconds. Experiments were
performed at room temperature (22–26°C). Relative conductance was determined by measur-
ing tail current amplitudes at—80 mV. For each patch the conductance-voltage (G-V) relation-
ship was fitted with the Boltzmann equation:
G
Gmax
¼ 1
1þ exp  VV1=2 act
kact
 
where G is the value of the instantaneous tail current at each test voltage, Gmax is the maxi-
mum obtained tail current, V is the test voltage applied to the membrane, V1/2 act is the voltage
for half-maximal current activation, and kact (an index of the minimum number of elementary
charges that move through the electric ﬁeld to gate the channel) is the slope factor of the
Boltzmann term. V1/2 act is a convenient parameter to study the effect of BK channel modula-
tors since it is directly related to the energy required to open the channel. Single G-V curves
from a set of patches at each experimental condition were averaged to obtain the shown
G-V curves.
For single channel recordings, myocytes were obtained by enzymatic digestion after surgical
extraction of the aortic artery from previously euthanatized +/+ (wild-type) and −/− BKβ1 (β1-
knockout) C57BL/6 mice (sacrificed by cervical dislocation). Aortic arteries were digested en-
zymatically with a mixture of papain, bovine serum albumin (BSA) and collagenase (from
Sigma) solved in Hank solution containing (in mM): 125 NaCl, 5.36 KCl, 5 NaHCO3, 0.34
NaHPO4, 0.44 KHPO4, 10 glucose, 1.45 sucrose and 10 HEPES (pH adjusted to 7.4 with
NaOH 10N). After mechanical dispersion in 100 nM Ca2+ recording solution, containing (in
mM): 140 KCl, 5 EGTA, 10 HEPES, 0.7 MgCl2, 2.4 CaCl2, (pH adjusted to 7.2–7.3 with TRIS-
BASE and 300 mOsm/l), vascular myocytes were seeded in plastic dishes (35 mm).
Electrophysiological studies were performed in the first 8 hours after the extraction of arteries.
Single-channel currents were recorded from inside-out macropatches clamped at 0 mV, pulsed
for 30 seconds at different depolarizing voltages using a gap-free protocol. Borosilicate glass
patch pipettes had 2–3 MO of resistance and were filled with a solution containing (in mM):
140 KCl, 1.2 MgCl2, 5 EGTA, 10 HEPES (300 mOsm/l, pH 7.35). All experiments were per-
formed at room temperature with the 100 nM Ca2+ free recording bath solution. Tungstate
(1 mM) was added to the bath solution with a fast perfusion system after a series of
control recordings.
Measurements of KCa3.1 currents in 3T3 murine fibroblasts were performed as described
previously [38]. In brief, membrane currents were recorded in the standard whole-cell mode
by using an EPC10-USB patch-clamp amplifier (HEKA, Germany) and voltage ramps ranging
from-100 mV to +100 mV (duration 1 sec). The KCl-pipette solution-suitable as intracellular
solution for KCa channel recording and activation- contained (in mM): 140 KCl, 1 MgCl2, 2
EGTA, 1.71 CaCl2 (1 μM [Ca
2+]free) and 5 HEPES (adjusted to pH 7.2 with KOH). The bath
solution contained (in mM): 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, and 10 HEPES
(pH 7.4).
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The pClamp8, PatchMaster and FitMaster softwares were used for pulse generation, data
acquisition, and subsequent analysis. Currents were recorded at 10 kHz and low-pass-filtered
at 1 kHz.
FRET experiments
Ratiometric FRET was obtained by excitation (458 nm) of the CFP-Gβ CFP and emission
(514 nm) of Gα-YFP YFP in a Leica TCS SP5 confocal microscope equipped with a 63x Oil ob-
jective and analyzed using the ImageJ software. R0 (the distance at which 50% energy transfer
takes place) for the donor-acceptor CFP/YFP FRET pair has been reported to be 4.92 nm [39].
All FRET experiments were carried at room temperature and the cells were bathed in a solution
containing (in mM): 140 NaCl, 1 MgCl2, 1.2 CaCl2, 10 HEPES, 5 glucose, 0.5 EGTA (300
mOsm/l and pH 7.2–7.3). Noradrenaline (NA) was added to this bath solution in order to de-
termine agonist-induced changes in FRET from HEK293 cells transfected with cDNAs encod-
ing Gα-YFP, CFP-Gβ, Gγ and α2A-AR.
Proliferation assays
Human renal VSMCs at passages 3–8 were seeded onto poly-l-lysine coated coverslips placed
in 12 mm wells at a density of 20,000 cells/well. Cells were maintained in control medium
for 24 hours and synchronized in serum free (SF) medium during 48 hours. Then, PDGF
(20 ng/ml) was added for an additional 24 hours period. Tungstate and/or the BK channel
blocker IbTX were added one hour before and remained present during PDGF stimulation.
The percentage of cells at the S phase was quantified using EdU (5-ethynyl-2´-deoxyuridine)
incorporation for another 6 hours with a commercial kit (Click-iT EdU Imaging Cell Prolifera-
tion Assay, Invitrogen). Finally, cells were incubated with Hoechst before mounting with Vec-
tashield (Vector Laboratories Inc.,Burlingame, CA). EdU incorporation was visualized with an
immunofluorescence microscopy (Nikon) at the corresponding wavelength depending on the
Alexa Fluor used and was expressed as the percentage of the total cell number stained with
Hoechst. In each experiment, this percentage was an average of 10 to 20 high power fields per
coverslip. Triplicates were made for each condition.
Ethics Statement
Protocols to obtain human renal arteries from donors at the Clinic Hospitals of Barcelona and
Valladolid, were approved by the Human Investigation Ethics Committee of the Hospitals.
These samples belong to the COLMAH collection of the HERACLES network (http://www.
redheracles.net/plataformas/en_coleccion-muestras-arteriales-humanas.html).
Murine aortic arteries were obtained from mice sacrificed by cervical dislocation. Animal
protocols for in-vitro studies were performed in agreement with ARRIVE guidelines and the
Spanish legislation on protection of animals, specifically approved by the local Institutional
Animal Care and Use Committee (Comité Ético de Experimentación Animal del Consorci
Parc de Recerca Biomèdica de Barcelona, including Universitat Pompeu Fabra) (Approval ID:
JMC-07–1001P2) and conformed to the Directive 2010/63/EU of the European Parliament.
Statistics
Data are presented as means ± S.E.M. For statistical comparison of two and more groups we
used the Student’s t test, Mann-Whitney U-test, One Way Analysis of Variance (ANOVA) fol-
lowed by Tukey post hoc test, or Nonparametric ANOVA (Kruskal-Wallis Test) followed by
Dunn post hoc test, where appropriate. Differences were considered significant if P< 0.05.
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Results
BKαβ1 channels play a role in the Gi/o protein-dependent ERK1/2
phosphorylation induced by tungstate
We have previously reported that tungstate only promoted the activation of heterologously ex-
pressed BK channels in the presence of regulatory β1 or β4 subunits [14]. In order to evaluate
the possible role of BK channels in the tungstate-mediated activation of the ERK pathway, we
analyzed ERK1/2 phosphorylation using phospho-specific antibodies. Western blot analysis of
phosphorylated ERK1/2 was carried out in tungstate (1 mM)-treated non-transfected HEK293
cells, HEKα cells (constitutively expressing the human α subunit of the BK channel), and
HEKαβ1 cells (constitutively expressing the bovine α and β1 subunits of the BK channel).
Tungstate increased the phosphorylation of ERK1/2 in all HEK293 cell lines, although to a sig-
nificantly higher level in HEKαβ1 cells (P< 0.001) (Fig. 1A, and 1B). Such enhanced ERK
phosphorylation induced by tungstate in HEKαβ1 cells was prevented by pretreatment with ei-
ther the Gi/o protein inhibitor pertussis toxin (PTX, 100 ng/ml) (Fig. 1C, 1D) or the specific BK
channel blocker iberiotoxin (IbTX, 100 nM) (Fig. 1E, 1F). Both toxins were without effect on
the EGF/IGF-induced ERK phosphorylation that we used as control for ERK activation.
BKαβ1 channels function upstream of Gi/o protein activation induced by
tungstate
Since the BKαβ1 channel-dependent enhancement of tungstate-induced ERK phosphorylation
was prevented by inhibition of Gi/o proteins, we next evaluated whether the BK channel operat-
ed either upstream or downstream of the G protein signaling. For this purpose, we analyzed
the effect of tungstate on heterologously expressed BKαβ1 channels in the presence of GDPβS
(500 μM) that locked the Gα protein subunit in its inactive (GDP-bound) state or after pre-in-
cubation of the transfected cells with PTX (500 ng/ml). Fig. 2 (A, C) shows representative
BKαβ1 currents, recorded before (control) and after the addition of 1 mM tungstate (WO4
2-) to
a nominally Ca2+-free bath (intracellular) solution containing 0.7 mMMg2+ (an intracellular
cation required for the tungstate-induced activation of BK channels [14]). Changes in BKαβ1
channel activity were determined by plotting the G-V relationships of the measured BK tail
currents, before and after exposure to tungstate (Fig. 2B, 2D). For each G-V curve, the voltage
for channel half-activation (V1/2 act) was calculated (Fig. 2E). We found that even in the pres-
ence of G-protein inhibitors, tungstate still decreased by ~16–25 mV the V1/2 act for BKαβ1
channels (P< 0.01, paired t-test), favouring channel activation by voltage. This action of tung-
state on BKαβ1 channels was similar to the one we have previously reported (a decrease
of V1/2 act by ~22 mV), under identical experimental conditions but without interfering with
the activation of G proteins [14]. Thus, these results ruled out an involvement of G proteins in
the tungstate-induced activation of BKαβ1 channels. Instead, the data suggested that the BK-
mediated and Gi/o-dependent phosphorylation of ERK1/2 induced by tungstate involved the
activation of Gi/o proteins downstream of tungstate interaction with the BK channel. To further
test this idea, we evaluated whether Gi protein activation by tungstate was related to the pres-
ence of BKαβ1 channels. G protein activation was evaluated by measuring the Fluorescence
Resonance Energy Transfer (FRET) between αi and β subunits of the heterotrimeric G protein
tagged with the yellow fluorescent protein (YFP) and the cyan fluorescent protein (CFP), re-
spectively. It has been reported that G protein subunits undergo a molecular rearrangement
during activation (rather than a complete dissociation). Thus, when the CFP was fused to the
N-terminus of the Gβ subunit, activation of the G protein following stimulation of Gi protein-
coupled adrenergic α2A receptors (α2A-ARs) with noradrenaline (NA) resulted in an increase
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Fig 1. BKαβ1 channels potentiate tungstate-induced ERK1/2 phosphorylation in a Gi/o protein-dependent manner. Phosphorylation of ERK1/2 was
analyzed byWestern blot using phospho-ERK-specific antibodies. Total ERK was used as loading control (data not shown). Protein expression and
phosphorylation were quantified by densitometry of the correspondingWestern blot signal. Relative density (phosphorylated versus total ERK) was
normalized to the inner control (EGF/IGF for each condition, which was considered as 100%). (A) Representative Western blots obtained from HEK293,
HEKα and HEKαβ1 cells for ERK1/2 phosphorylation levels, without treatment (-) or after treatment with 1 mM tungstate (WO4
2-) (during 5 and 10 minutes, as
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in FRET (measured as an elevation of the ratio between YPF and CFP fluorescence emission
(FYFP/FCFP)) [40].
Gαi-YFP and CFP-Gβ subunits (along with the Gγ subunit) were heterologously expressed
in HEKα and HEKαβ1 cells and FRET measurements were carried out before and after the ad-
dition of tungstate. Changes of FRET in response to noradrenaline (NA) in HEK293 cells co-
expressing the above mentioned G protein subunit constructs along with α2A-ARs, were used
as positive control. Cells with a reinforced membrane fluorescence pattern (Fig. 3A), indicating
the co-localization of the expressed fluorescent G protein subunits in the cellular membrane,
were selected for FRET measurements. Addition of tungstate (1 mM) only increased FRET in
HEKαβ1 but not in HEKα cells expressing Gβi-YFP and CFP-Gβ subunits (Fig. 3B (magenta
and blue traces, respectively) and 3C). As previously reported [40], addition of NA (1 μM) to
HEK293 cells co-transfected with the cDNAs of G protein subunits and the α2A-AR, resulted
in an increase in FRET (elevated FYFP/FCFP ratio) (Fig. 3C). No increase in FRET after addition
of NA was seen when the cDNA of the α2A-AR was omitted in the cell transfection process
(Fig. 3C). The tungstate-induced elevation of the FRET signal in HEKαβ cells was about 56%
of that produced by NA in HEK293 cells co-expressing the α2A-AR (Fig. 3C). Furthermore, as
observed for the enhanced tungstate-induced phosphorylation of ERK found in HEKαβ1 cells
(Fig. 1E, 1F), the increase in FRET among G protein subunits after tungstate application was
abolished by pre-incubating the HEKαβ1 cells with IbTX (Fig. 3B (dark purple trace) and 3C).
Together, these data suggested that tungstate-targeting of the BKαβ1 channel promoted Gi
protein activation.
Tungstate effect on Ca2+-activated K+ channels is specific for BK
channels
We evaluated whether the tungstate effect on BK channel activity applied also to other distantly
related Ca2+/calmodulin-gated K+ channels, in particular the KCa3.1 (IK1) channel that has
been previously related to the direct activation of the ERK signaling pathway. S1 Fig. shows
that pre-activated (by 1 μM intracellular Ca2+) KCa3.1 currents recorded from murine 3T3 fi-
broblasts were insensitive to 1 mM tungstate, even after current potentiation by the KCa3.1
channel activator SKA-31 [41].
Tungstate-induced activation of native BK channels in vascular smooth
muscle cells depends on the expression of the regulatory BK channel β1
subunit
We have previously reported that the positive action of tungstate on BKαβ1 channel activity,
found in a heterologous expression system, was likely to be responsible of the tungstate-in-
duced vasodilatation of mouse arteries pre-contracted with endothelin-1. This conclusion was
based on two experimental evidences: tungstate-induced vasorelaxation depended on the ex-
pression of the regulatory β1 subunit (vasorelaxation was lost in β1-knockout arterial rings)
and it was not related to the reported tungstate-induced inhibition of the endothelial xanthine
indicated) in the absence of toxins. (B) Average normalized relative density (phosphorylated versus total ERK) in the absence of toxins. (C) Representative
Western blots obtained from HEK293, HEKα and HEKαβ1 cells for ERK1/2 phosphorylation levels, without treatment (-), after treatment with 100 ng/ml EGF
(during 10 minutes) (EGF) or after treatment with 1 mM tungstate (WO4
2-) (during 5 and 10 minutes, as indicated) in the absence (left) or presence of PTX
(right). (D) Average normalized relative density (phosphorylated versus total ERK) in the presence of PTX. (E) Representative Western blots obtained from
HEK293, HEKα and HEKαβ1 cells for ERK1/2 phosphorylation levels, without treatment (-), after treatment with 100 ng/ml IGF (during 10 minutes) (IGF) or
after treatment with 1 mM tungstate (WO4
2-) (during 5 and 10 minutes, as indicated) in the absence (left) or presence of IbTX (right). (F) Average normalized
relative density (phosphorylated versus total ERK) in the presence of IbTX. n = 4–12 in each experimental group. *P< 0.05 when compared to the other HEK
cell lines (Kruskal-Wallis test followed by Dunn post hoc test). See Methods for further details.
doi:10.1371/journal.pone.0118148.g001
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Fig 2. Tungstate-mediated activation of BKαβ1 channels is independent of G proteins.Representative currents recorded from excised inside-out
macropatches obtained from HEK293 cells expressing the BKαβ1 channels in the presence of 500 μMGDPβS (added to the bath solution) (A) or from
transfected HEK293 cells pre-incubated with PTX (500 ng/ml, 24 hours) (C). Currents were recorded at cytosolic 0 Ca2+ and 0.7 mMMg2+ before (control, top
panels) and 5–10 minutes after cytosolic application of 1 mM tungstate (WO4
2-, bottom panel). The voltage protocol was as described in the Methods. (B), (D)
Average G-V curves for BKαβ1 channels under the experimental conditions above mentioned. Solid curves were obtained by fitting the normalized
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oxidase (XO) [8] as it was not replicated by the XO blocker allopurinol [14]. We have now
studied directly the effect of tungstate on BK channels endogenously expressed in murine vas-
cular smooth muscle cells (VSMCs). Single-channel recordings showed that BK channel open
probability (NPo) increased in response to 1 mM tungstate only in inside-out patches obtained
from VSMCs of wild-type mice but not in those from β1- knockout mouse VSMCs (Fig. 4).
Tungstate promotes ERK1/2 phosphorylation and reduces PDGF-
stimulated cell proliferation in human vascular smooth muscle in a BK
channel-dependent manner
We next analyzed whether tungstate also promoted ERK phosphorylation in human VSMCs
and its relationship with the BK channel. Similar to that seen in HEKαβ1 cells (constitutively
expressing the bovine α and β1 subunits of the BK channel), treatment of human VSMCs with
tungstate (1 mM for 10 minutes) promoted the phosphorylation of ERK1/2 up to slightly
lower levels than PDGF treatment although this difference did not reach statistical significance
(P> 0.05, ANOVA followed by Tukey post hoc test). Such tungstate-induced ERK phosphory-
lation in human VSMCs was significantly reduced by pretreatment with the specific BK chan-
nel blocker iberiotoxin (IbTX, 100 nM) (Fig. 5A and 5B). As Gβγ-stimulated ERK1/2
phosphorylation has been reported to lead to differentiation of VSMCs to a contractile pheno-
type [36, 37], we also studied the effect of tungstate on PDGF-induced human VSMC prolifera-
tion. For this analysis, we lowered tungstate to 100 μM because we have previously reported
that at this lower concentration, tungstate still promoted voltage-dependent activation of
BKαβ1 channels and induced vasorelaxation in endothelin-1-pre-contracted mouse arteries
[14]. Besides, such tungstate concentration is only slightly higher than the tungstate levels mea-
sured in the plasma of both experimentally treated rodent models and humans (~5–20 μM)
[2, 42]. We found that 100 μM tungstate strongly reduced the proliferative action of PDGF (the
effect was similar when using 1 mM tungstate). IbTX prevented significantly this inhibition.
IbTX alone had no significant effect on PDGF-induced VSMC proliferation (Fig. 5C).
Discussion
Tungstate is a transition metal that exerts antidiabetic [2, 43], antiobesity [6] and antihyperten-
sive actions [8–10] in several experimental animal models. Despite considerable knowledge on
the pharmacological and metabolic effects of tungstate, little information exists regarding its
molecular mechanisms of action. In this sense, it is known that tungstate triggers intracellular
signaling pathways related to the activation of extracellular signal-regulated kinases (ERK) in
several cell types [4, 11, 12]. This signaling action of tungstate mimics the effect of insulin in
hepatocytes, by increasing glycogen deposition but in an insulin receptor-independent manner.
conductance to the Boltzmann equation (see Methods). (E) Voltage for half maximal activation (V1/2 act) of BKαβ1 channels before (control, filled circles) and
after addition of tungstate (1 mMWO4
2-, open circles) obtained for the indicated experimental conditions (+GDPβS, n = 4; +PTX, n = 6). No significant
difference was found in the decrease on V1/2 act induced by tungstate when comparing both treatments: 24 ± 4 mV (n = 4) for GDPβS treatment versus 16 ± 3
mV (n = 6) for PTX treatment (P = 0.11, Mann-Whitney U-test). Besides the substantial difference in the duration of both treatments to inhibit G proteins (24–
28 hours for PTX treatment and minutes for GDPβS treatment), no significant difference was found among them regarding V1/2 act before the addition of
tungstate (control situation for GDPβS treatment: V1/2 act = 144 ± 4 mV (n = 4) versus control situation for PTX treatment: V1/2 act = 145 ± 2 mV (n = 6); P>
0.99, Mann-Whitney U-test). Furthermore, these V1/2 act control values (before tungstate application) were similar to the ones previously reported by us under
identical experimental conditions but without interfering with the activation of G proteins: 139 ± 2 mV (n = 7) [14] and 147 ± 2 mV (n = 7) [26] (P = 0.1,
ANOVA). Note that, as previously reported, 1 mM tungstate also reduced substantially the K+ current amplitude in the absence of cytosolic Ca2+ (A, C), an
effect that, contrary to the tungstate-induced reduction of V1/2 act, has been shown to occur either in the absence or presence of Mg
2+ and in the absence or
presence of the different regulatory β subunits (β1-β4) [14]. For each experimental condition V1/2 act and kact values were (in mV): 144 ± 4 and 20 ± 0.3 (control
situation for GDPβS treatment, n = 4); 120 ± 1 and 22 ± 1 (after WO4
2- addition for GDPβS treatment, n = 4); 145 ± 2 and 19 ± 0.3 (control situation for PTX,
n = 6); 129 ± 2 and 21 ± 1 (after WO4
2- addition for PTX treatment, n = 6). No significant differences were found among kact values (P = 0.07, ANOVA).
doi:10.1371/journal.pone.0118148.g002
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Fig 3. Tungstate-induced activation of heterologously expressed Gi/o proteins is mediated by BKαβ1 channels. (A) Example of the reinforced
membrane fluorescence pattern and emission levels from CFP channel (up-left), YFP (FRET channel) (up-right) and the merge channels (bottom-left) from
HEK293 heterologously expressing Gαi-YFP and CFP-Gβ. Fluorescence microscopy images were recorded by using confocal microscopy (for more details
see Methods). FRET signal was determined by using donor ratiometric parameters (458/514) after excitation in the CFP frequency and registering in the YFP
emission frequency. (B) Representative FRET changes from HEK293, HEKα or HEKαβ1 cells transfected with the cDNAs of G protein subunits, in response
to 1 mM tungstate (either in the absence or presence of IbTX), as indicated. (C), Average FRET changes for the different experimental conditions illustrated
in B (n = 5–9). *P< 0.05 (Kruskal-Wallis test followed by Dunn post hoc test).
doi:10.1371/journal.pone.0118148.g003
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Tungstate activates PTX-sensitive Gi proteins that in turn activate the small GTPase Ras to
produce the phosphorylation of ERK, the subsequent phosphorylation of p90rsk and glycogen
synthase kinase-3β, and the activation of glycogen synthase leading to glycogen deposition
[4, 13]. The antihypertensive effect of tungstate has been linked to both the inhibition of the
endothelial xanthine oxidase [8] and the activation of the large conductance voltage- and
Ca2+-activated K+ (BK) channel at the vascular smooth muscle cells (VSMCs) [14]. Vascular
BK channels are formed by the pore-forming α (KCNMA1) and the regulatory β1 (KCNMB1)
subunits. Indeed, we reported previously that tungstate only activates BK channels containing
either the β1 or the β4 (but no β2 or β3) subunits [14, 26].
Here, we provide evidence that tungstate-targeting of β1 subunit-containing BK channels
promotes the activation of PTX-sensitive Gi proteins to enhance the tungstate-induced phos-
phorylation of ERK (Fig. 6). First, we observed significant higher levels (~40–44%) of ERK
phosphorylation after tungstate treatment in HEK293 cells expressing both BK channel α and
β1 subunits (HEKαβ1 cells) than in cells that did not express BK channels (HEK293 cells) or ex-
pressed the BK pore-forming α subunit alone (HEKα cells). Second, the fact that such
Fig 4. Tungstate-induced increase in the open probability of BK channels endogenously expressed in freshly isolated vascular myocytes requires
the BK channel β1 subunit. (A) Representative recordings obtained from inside-out patches clamped at + 60mV from wild-type (WT) and β1- knockout
freshly isolated mouse vascular myocytes, before (control) and after exposure to 1 mM tungstate (1 mMWO4
2-), as stated. Arrows indicates the closed state
level. (B) Average changes (in %) of BK channel open probability (NPo) induced by 1 mM tungstate onWT and β1- knockout mouse vascular myocytes at the
indicated voltage membrane. Significant differences were found amongWT (n = 7) and β1- knockout (n = 9), P< 0.001 (Student’s t-test). Further
depolarization to +80 mV of β1- knockout inside-out patches did not change the response to tungstate found at +60 mV.
doi:10.1371/journal.pone.0118148.g004
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Fig 5. BK channels mediate both ERK1/2 phosphorylation and reduction of PDGF-stimulated
proliferation induced by tungstate in human vascular smoothmuscle cells. (A) Representative
Western-blot showing phosphorylation of ERK1/2 using phospho-ERK-specific antibodies after 10 minutes
incubation in control conditions (0% FBS), with PDGF (20 ng/ml), and with tungstate (1 mM) alone or in
combination with iberiotoxin (IbTX 100 nM), as indicated. Beta-actin was used as loading control. (B) Protein
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enhancement of the tungstate-induced activation of the ERK pathway found in HEKαβ1 cells is
prevented by either PTX or IbTX, supports the involvement of both Gi/o proteins and BK chan-
nels in this signaling process. Third, Gi/o proteins are not upstream of the tungstate-induced ac-
tivation of BKαβ1 channels, since tungstate-induced changes in BK channel activity remains
unaltered even in the presence of the G protein inhibitors PTX or GDPβS. This observation is
in agreement with previous electrophysiological data and comparative structural analysis sug-
gesting that tungstate modulates BK channel activity by direct binding to a site located at the
BK α subunit (around residues of the voltage sensor and the RCK1 domains that coordinate
the binding of Mg2+) [14], with the required participation of β1 subunit extracellular loop resi-
dues that stabilize the active configuration of BK channel voltage sensor [26]. And fourth,
BKαβ1 channels seem to be upstream in the tungstate-induced, Gi/o protein-mediated ERK
expression and phosphorylation were quantified by densitometry of the corresponding Western blot signal
and normalized to beta-actin. The ratio p-ERK/beta-actin in control conditions was taken as 1, so that fold-
changes relative to control are shown. (C) VSMCs were serum starved for 48 hours and then incubated 30
hours with 20 ng/ml PDGF alone or in combination with the indicated compounds. During the last 6 hours of
incubation, EdU was added to the media to detect the number of cells entering S-phase. Mean ± S.E.M. of
6–9 determinations from at least four different cultures. ***P< 0.001 (ANOVA followed by Tukey post hoc
test).
doi:10.1371/journal.pone.0118148.g005
Fig 6. Schematic representation of BKαβ1 channel’s role in tungstate-induced, Gi protein-mediated ERK phosphorylation and its interaction with
PDGF-stimulated cell proliferation in human vascular smoothmuscle. PDGF stimulates both the Ras/Raf/MEK/ERK and the phosphatidylinositol 3-
kinase (PI3K)/Akt mitogenic signaling pathways to induce vascular smooth muscle cell (VSMC) proliferation [35]. Tungstate (WO4
2-) binding to the BK
channel α subunit at a site involving residues of the Voltage Sensor Domain (silver circles in the S0–S1 and S2–S3 linkers) [14, 26] promotes activation of the
voltage sensor and channel gating in a β1 subunit-dependent manner, and subsequently, activation of PTX-sensitive G proteins to induce ERK
phosphorylation and inhibition of PDGF-stimulated VSMC proliferation. Binding of iberiotoxin (IbTX) to the external mouth of the channel in close proximity to
the β1 extracellular loop, which plays an important role in the modulation of voltage sensor activation and gating of the BK channel [21, 46–53], may impair
the conformational changes in the BKαβ1 channel produced by tungstate to prevent the coupling of channel gating to G protein activation without the need of
K+ conduction. For further details, please see Discussion.
doi:10.1371/journal.pone.0118148.g006
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phosphorylation pathway. Thus, tungstate only activated heterologously expressed Gi proteins
(indicated by an increase in FRET among Gαi-YFP and CFP-Gβ subunits) in HEKαβ1 cells,
but no in HEKα cells, an effect that was prevented by the blockade of BKαβ1 channels with
IbTX. Altogether, these results suggest that BKαβ1 channels might well act as tungstate recep-
tors to trigger the activation of the ERK pathway. Among Ca2+-activated K+ channels, such
tungstate receptor function seems to be specific for BKαβ1 channels: we observed that the IK1
channel, which has been related to the direct activation of the ERK signaling pathway [30], is
tungstate-insensitive.
Given that the BK β1 channel subunit is primarily found in VSMCs, where it improves
channel function for a better fine-tuned and efficient negative feedback on vascular tone [19,
20], the functional relationship between BKβ1 channels and the Gi/o protein-ERK signaling cas-
cade might also have physiological and/or pathological relevance in the vascular beds. It is well
established that phenotypic remodeling of VSMCs, involving changes from contractile toward
a more proliferative phenotype caused by mitogen-stimulated gene expression, occurs during
the pathogenesis of hypertension, atherosclerosis or vascular restenosis [31, 32]. Therefore,
treatments that oppose such remodeling and promote VSMC re-differentiation can be of help
in the management of pathological vascular remodeling. Growth factors such as platelet-de-
rived growth factor (PDGF), by acting on specific tyrosine kinase receptors, stimulate several
mitogenic signaling pathways that lead to VSMC proliferation: (i) phospholipase C (PLC) iso-
forms that increase the cytosolic Ca2+ levels and activate protein kinase C, (ii) the Ras/Raf/
MEK/ERK pathway, and (iii) the phosphatidylinositol (PI) 3-kinase/Akt pathway [35]. These
same intracellular signaling routes promote VSMC differentiation in response to serum com-
ponents such as thrombin, acting via G-protein coupled receptors and Gi/o βγ dimmers [35–
37]. The opposite effects produced by these two kinds of agonists regarding the modulation of
VSMC phenotype seem to be due to differences in both the intensity of the signals and their ki-
netic patterns, along with the cross-talk between pathways [35]. Thus, upon stimulation of ty-
rosine kinase receptors there is a rapid and strong phase of ERK phosphorylation and a robust
PI 3-kinase-dependent and sustained Akt phosphorylation, which prevents the generation of a
late ERK activation phase by inhibiting Raf kinase activity and suppressing MEK (Fig. 6) [35].
Interestingly, it has been reported that growth factor-dependent mitogenesis relies on two dis-
tinct signaling phases. The first phase involves MEK/ERK and c-Myc activation to make cells
go through the initial phase of the G0 to S cell cycle interval. Such first phase is required to en-
gage the components necessary for cell cycle progression during a second phase that depends
exclusively on PI 3-kinase lipid products [44]. However, after agonist binding to GPCR and
G protein activation, G βγinduces not only the rapid and strong phase of ERK phosphorylation
but also a late phase that is required for changes in gene expression leading to VSMC differenti-
ation. Such second phase of ERK activation can occur because, in this case, Akt phosphoryla-
tion is weak and transient and fails to inhibit Raf kinase activity [35].
Here we show that the open probability of endogenous BK channels in murine VSMCs is in-
creased by tungstate in a β1-dependent manner. This result is consistent with our previous data
showing that tungstate activates BK channels containing either the β1 or the β4 (but not β2 or
β3) subunits in a heterologous expression system, and that tungstate-induced relaxation of
mouse pre-contracted blood vessels depends on the expression of the regulatory BK β1 subunit
[14]. Functional BK channels have been also recorded from the cultured human renal VSMCs
used in this study (data not shown). In addition, expression studies in proliferating VSMCs
show that they retain expression of both BKα and BKβ1 mRNA, presenting an increase of
BKαβ4 mRNA [45]. We have now found that targeting of vascular BK channels by tungstate
also promotes phosphorylation of ERK in human renal VSMCs. Furthermore, tungstate inhib-
its the PDGF-stimulated human VSMC proliferation, in a process that is also mediated, at least
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in part, by BK channels (Fig. 6). However, further research is required in order to establish
whether the activation of the Gi/o protein/ERK pathway lies behind such antiproliferative ac-
tion of tungstate, by allowing the late phase of ERK phosphorylation. In this sense, it has been
shown that abrogation of the PI 3-kinase/Akt signaling changes the PDGF-induced prolifer-
ative VSMC phenotype toward enhanced expression of contractile proteins [35].
The question of how the targeting of BKαβ1 channels by tungstate leads to the activation of
Gi/o proteins (and the subsequent ERK phosphorylation and inhibition of VSMC proliferation
stimulated by PDGF), needs to be answered by future studies. Nonetheless, the fact that this
signaling process is abolished in the presence of the BK channel blocker IbTX, might initially
suggest that the conduction of K+ ions through the tungstate-activated channel is involved in
G protein activation. IbTX shares a high sequence identity (around 68%) with charybdotoxin
(ChTX) and a similar mechanism for BK channel blockade has been suggested [46]. The exact
interaction site for the toxins in BK channels is not clear but the involvement of residues
around the outer mouth pore of the channel has been proposed [47]. In agreement, the crystal
structure of a mutant form of the voltage-gated K+ channel KV1.2 in complex with ChTX indi-
cates that the toxin binds to the extracellular pore entryway and interacts directly with K+ in-
side the selectivity filter [48]. Furthermore, some residues in the extracellular loop of the BK
regulatory β1 subunit are responsible of the high BK channel affinity for ChTX [21, 49]. These
β1 loop amino acids are in close proximity to the external mouth and, perhaps, the selectivity
filter and gate of the channel [49–51]. Besides, different studies indicate that the β1 extracellular
loop plays an important role in the modulation of voltage sensor activation and gating of the
BK channel [52, 53]. Therefore, toxin binding to the BKαβ1 channel may also modify the struc-
tural changes related with the activation of the voltage sensor and channel gating. Then, toxin
impairment of the conformational changes in the BKαβ1 channel produced by tungstate may
affect the coupling of channel gating to G protein activation without the need of K+ conduction
(Fig. 6). In support of this hypothesis, we have found that two distinct concentrations of tung-
state (100 μM and 1 mM), which increase and reduce (respectively) K+ flux through vascular
BKαβ1 channels, equally inhibit PDGF-induced cell proliferation in human vascular smooth
muscle (Fig. 5C). Indeed, 1 mM tungstate has a dual effect on heterologously expressed BKαβ1
channels: it reduces (by ~ 30–40%) the amplitude of K+ currents (an effect that is equal for BK
channels containing or not the different regulatory β subunits, β1-β4) and favors channel acti-
vation by voltage (i.e. decreases V1/2 act by ~ 20 mV) in a Mg
2+- and β1 subunit-dependent
manner [14]. From previous studies of tungstate effects on murine arterial contractility, and
given the key role of BKαβ1 channels in this process [18–20], it can be inferred that the negative
action of 1 mM tungstate on vascular BK current amplitude outweighs its positive effect on the
voltage-dependent activation of the channel. Thus, a net reduction of vascular BK currents can
explain the constriction of arterial rings from both wild-type (WT) and β1-knockout mice in-
duced by 1 mM tungstate [14]. On the contrary, at micromolar levels (100 μM) tungstate still
promotes voltage-dependent activation of the vascular (β1 subunit-containing) BK channel
without reducing K+ current amplitude. The resulting net increase in the activity of vascular
BKαβ1 channels explains why 100 μM tungstate only promotes relaxation of WT but not β1-
knockout mouse arteries pre-contracted with endothelin-1 [14].
In the same line of thought, it has been shown that activation of the ERK signaling pathway
mediated by IK1 channels does not require the capability of this channel to conduct K+ ions
[30]. There are evidences that support the existence of a direct protein-protein crosstalk among
BK channels and some G-protein coupled receptors, such as μ-opioid [54] or thromboxane A2
receptors [55]. In addition, it has been shown that BK α channel subunit can directly interact
with Gβγ dimmers [56].
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In summary, our data provide evidence to consider BK channels as another member of the
growing list of channels directly involved in the transduction of intracellular signals, beyond
their ion-conducting function [29, 30]. Our results further highlight the relevance of BK chan-
nel function in VSMCs, apart from its well known role in reducing cell contractility to promote
vasorelaxation, arising also as a potential target for the modulation of the growth factor-in-
duced proliferative phenotype associated with certain vascular pathologies. In this sense, the
functional interaction between tungstate and vascular BKαβ1 channels become an interesting
starting point to develop new antihypertensive therapies [14, 57].
Supporting Information
S1 Fig. Tungstate has no effect on KCa3.1 (IK1) channel activity. (A) Whole-cell recordings
of KCa3.1 in murine 3T3 fibroblasts. KCa3.1 currents were pre-activated by infusion of 1 μM
Ca2+ via the patch-pipette as previously described [38]. Pre-activated currents (control) were
not changed by 1 mM tungstate (1 mMWO4
2-). (B) Average data showing pre-activated
KCa3.1 current densities before and after tungstate application (P> 0.99, Mann-Whitney U-
test; n = 4). (C) Average changes (in %) of pre-activated KCa 3.1 currents in response to 1 mM
tungstate (1 mMWO4
2-) in the absence or presence of KCa3.1 activator SKA-31, as indicated.
The SKA-31-potentiated KCa3.1 current was likewise insensitive to 1 mM tungstate (P = 0.56,
Mann-Whitney U-test). Numbers in brackets indicate the number of cells tested in each
experimental condition.
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